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The ability of MALDI-MS to analyze photolabile arylazido peptide derivatives was investi-
gated. Peptides containing UV-labile p-azidobenzoyl groups were subjected to MALDI-MS
analysis in a variety of matrices. As standard MALDI-MS employs a UV laser (337 nm), we
investigated conditions that would allow detection of the intact molecule ions for these
light-sensitive peptides. When using -cyano-4-hydroxycinnamic acid (ACHC) or 2,5 dihy-
droxybenzoic acid (DHB) as the matrix, photoinduced degradation products were prevalent.
In contrast, when employing the matrix sinapinic acid, the intact molecule ion corresponding
with the azido peptide was the predominant signal. The protection of photolabile azido
derivatives correlates with the UV absorbance properties of the matrix employed, i.e., sinapinic
acid, which exhibits a strong absorbance near 337 nm, most efficiently protects the azido
derivative from photodegradation. (J Am Soc Mass Spectrom 2004, 15, 1156–1160) © 2004
American Society for Mass SpectrometryPhotoactivatable reagents are powerful tools in thestudy of molecular interactions [1, 2]. The mostcommonly used photoactivatable group for pro-
tein and peptides is the arylazido group. Arylazido mod-
ified peptides can be prepared by reacting an activated
p-azidobenzoic acid derivative with amino groups
present either at the N-terminus or at lysyl side chains.
Activation of these p-azidobenzoyl peptides is achieved
by UV-light irradiation resulting in a loss of nitrogen (N2)
and formation of a reactive nitrene intermediate. The
reactive species can then form a covalent bond with a
nearby protein chain. The reaction is likely to take place in
the vicinity of the activated species. The covalent crosslink
can thus lead to the identification of a binding site, e.g., of
a ligand and a receptor or a substrate and an enzyme.
A convenient way of preparing azidobenzoyl pep-
tides involves reacting the peptide with an activated
azidobenzoic acid derivative, such as the hydroxysuc-
cinimidyl ester. These reagents react with the primary
amino groups in the peptide, the N-terminal amino
group or the -amino group in lysyl residues. In cases
where several amino groups are present, one or more of
these reactive groups can become modified. It is impor-
tant to determine which amino group carries the mod-
ification to reproducibly generate the one that exhibits
the highest affinity for its receptor or other binding
partner. The full characterization of photolabile compo-
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dures involve the use of UV light, e.g., UV detection
during HPLC purification and UV laser irradiation
during MALDI-MS analysis. We have therefore inves-
tigated conditions for MALDI-MS analysis that would
allow the detection of intact photoactivatable peptides.
The corticotropin releasing factor (CRF) family of neu-
ropeptides is involved in essential responses to stress [3].
Centrally, these peptides activate the pituitary adrenal
axis. Peripheral effects include an influence on blood
pressure as well as immune and inflammatory re-
sponses [4]. To date four members of the CRF peptide
family have been characterized in mammals [5]. The
receptors for the CRF peptides belong to the G-protein
coupled seven transmembrane receptor family. Two sub-
types of CRF receptors have been characterized that
exhibit differential affinity for the ligands [6, 7]. We have
recently identified the first extracellular domain of the
CRF type I receptor as playing a major role in agonist
and antagonist binding [8, 9]. In particular the synthetic
peptide antagonist Astressin binds the first extracellular
portion with high affinity. The present study resulted
from our interest in generating an Astressin analog that
could be used to photolabel the binding region of the
first extracellular domain of the type I CRF receptor.
Experimental
Azidobenzoylation of Astressin
DTyr12-astressin (0.07 mg) was reacted with N-hydro-
xysulfosuccinimidyl-4-azidobenzoate (1.8 mg, Piercer Inc. Received January 22, 2004
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dium phosphate buffer (pH 7) for 70 min at RT. The
reaction mixture was separated by reversed-phase
HPLC. The mobile phase consisted of 0.05% trifluoro-
acetic acid in water (A buffer) or in 90% acetonitrile/
water (B buffer). A narrow bore C-18 column from
Vydac (Hesperia, CA) was employed (particle size 5
m, column dimensions: 2.1  150 mm). UV absor-
bance was monitored at 210 nm. The three major
components were collected and further analyzed. All
manipulations were carried out in a darkened room and
samples were kept in tubes wrapped in aluminum foil.
V8 Peptidase Digest of Modified Peptides
The modified peptides collected after HPLC separation
(amount estimated at 10–20 g each) were lyophilized
and digested with 1 g V8 protease (Roche Biochemi-
cals, IN) in 50 l ammonium bicarbonate buffer (50
mM, pH 8.3). The digests were resolved by reversed
phase HPLC. The fractions were analyzed by MALDI-MS
to identify the modified proteolytic fragments.
MALDI-MS Analysis
MALDI-MS spectra were measured on an ABI-Persep-
tive DE-STR instrument. The instrument employs a
nitrogen laser (337 nm) at a repetition rate of 20 Hz. The
spectra were recorded in the delayed extraction mode.
The accelerating voltage was 20 kV. All spectra were
recorded in the positive reflector mode. Laser power
was kept to a minimum for all spectra which are sums
of 100 laser shots. The reported m/z values were
rounded to the nearest integer for clarity; all measured
masses were within 100 ppm of the calculated values.
Matrices (sinapinic acid and -cyano-4-hydroxycin-
namic acid) were prepared as saturated solutions in
0.3% trifluoroactetic acid and 30% acetonitrile. The
matrix 2,5-dihydroxybenzoic acid was prepared at 1
mg/ml in the same solvent mixture. All chemicals were
obtained from Sigma Chemical Company (St. Louis,
MO). Samples (1 pmol in 0.5 l) were mixed with an
equal volume of matrix solution on the target and
allowed to dry in a darkened room. Throughout the
procedure the target was kept away from light sources.
UV Spectra
UV spectra were recorded at a concentration of 45 M
in 0.3% trifluoroacetic acid and 30% acetonitrile/water
as solvent. This is the same solvent used for MALDI
matrices in the analyses described above.
Results and Discussion
The corticotropin releasing factor antagonist DTyr12-
astressin [10] was reacted with N-hydroxysulfosuccin-
imidyl-4-azidobenzoate. The peptide contains one ly-
sine residue and a free N-terminal amino group.Acylation can thus result in modification of either of the
amino groups or of both. Consistent with this fact, three
major products were isolated after HPLC separation.
Inspection of the sequence revealed that digestion with
V8 protease would generate separate fragments con-
taining the N-terminal amino acid and the single lysyl
residue. Digestion with V8 protease was carried out in
ammonium bicarbonate buffer at pH 8.3 for all three
products. An aliquot of the digestion mixture was
resolved by reversed phase HPLC. The HPLC fractions
as well as the crude digests were subjected to
MALDI-MS analysis. Analyses presented here were
carried out on the HPLC isolated peptides. For the
C-terminal peptide H-Gln-Leu-Ala-Gln-Glu*-Ala-His-
Lys*-Asn-Arg-Lys(pAzbz)-Leu-Nle-Glu-OH (Azido-
CtAst) the modified lysine is represented by Lys-
(pAzbz); the side chains of Glu* and Lys* are connected
by a lactam bridge. The N-terminal peptide pAzbz-Tyr-
His-Leu-Leu-Arg-Glu-OH (Azido-NtAst) is modified
by the p-azidobenzoyl moiety at the N-terminal ty-
rosine’s  amino group, represented by pAzbz-Tyr.
Initial analysis of the C-terminal peptide were carried
out employing -cyano-4-hydroxycinnamic acid
(ACHC) as the matrix. This matrix is commonly used
when analyzing peptides with molecular weights
5000 Da. The modified peptides exhibited a strong
signal 26 mass units lower than that expected for the
benzoylazido peptides (Figure 1a). Additional weak
signals were observed that were 10 and 43 mass units
lower than expected for the [M  H] of the modified
peptide. No significant signal was observed at m/z 
1805, the expected mass for the intact Azido-CtAst ([M
 H]mono  1804.96 Da). The major signal at m/z 
1779 is consistent with a loss of nitrogen (N2) and
addition of 2 hydrogen atoms (H) to the nitrene which
could have occurred during storage or purification of
the peptide or during analysis in the mass spectrometer.
To investigate these possibilities, the modified peptides
were analyzed in different matrices by MALDI-MS and,
to utilize an ionization procedure which does not in-
volve UV-irradiation, by ESI ion trap MS.
Figure 1b shows the MALDI-MS spectrum obtained
for Azido-CtAst using 2,5 dihydroxybenzoic acid
(DHB) as the matrix. The predominant species is again
observed at m/z  1779 with a minor signal present at
m/z  1795 while no sigificant signal could be observed
for the intact arylazido peptide (calculated [M  H] 
1805).
When using sinapinic acid as the matrix, the signal
corresponding to the intact photolabile peptide at m/z
1805 becomes the predominant signal (Figure 1c). In
addition, a strong signal at m/z  1779 and a very weak
signal at m/z 1762 were observed. To determine if any
of the photodegradation had taken place outside the
mass spectrometer, the analysis was also performed by
electrospray ionization on an ion trap instrument. The
predominant signal corresponded with the intact aryla-
zido peptide and none of the degradation products
were observed (data not shown). This indicates that the
1158 LOW ET AL. J Am Soc Mass Spectrom 2004, 15, 1156–1160photodegradation products were formed in the MALDI
mass spectrometer.
The N-terminal modified peptide (Azido-NtAst) was
analyzed employing the same matrices with similar
results (Figure 2). For this peptide, the mass of the intact
azidobenzoyl peptide was observed at m/z 975 (calcu-
lated [M  H]  975.48) in all three matrices. The
signal was the predominant one when using sinapinic
acid (Figure 2c) while in both ACHC and DHB, the
signal at m/z  949 was the strongest. An additional
signal of varying intensity was observed at m/z  965.
The spectra presented here were obtained employing
the minimum laser power for a signal-to-noise ratio of
at least 50:1. It was found that increasing laser power
Figure 1. Positive MALDI-MS spectrum of Azido-CtAst employ-
ing ACHC (a), DHB (b), and sinapinic acid (c) as matrix. The
signal for intact Azido-CtAst at m/z  1805 (calculated [M 
H]mono  1804.96 Da) is only detectable when using sinapinic
acid as the matrix. Degradation products are observed at m/z 
1795, 1779, and 1762.beyond this threshold lead to an increase in signal
intensity for the photodegradation products (data not
shown). The amount of sample loaded onto the target
did not have a major influence on the ratio between the
signals for intact and degradated pepides unless the
quantity became marginal and required an increase in
laser power to become detectable.
The mass differences between the expected [M 
H] of the arylazido peptides and their degradation
products are indicated in Figures 1a and 2a. The pho-
todegradation products are observed as signals at [M 
H  10], [M  H  26] and [M  H  43],
Figure 2. Positive MALDI-MS spectrum of Azido-NtAst employ-
ing ACHC (a), DHB (b), and sinapinic acid (c) as matrix. The
signal for intact Azido-CtAst at m/z  975 (calculated [M 
H]mono  975.48 Da) is the predominant species when using
sinapinic acid as the matrix. Degradation products are observed at
m/z  965 and 949.
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that of their photoactivation has been studied exten-
sively [1, 2]. The first step of the activation involves
elimination of N2 and formation of the reactive nitrene.
The nitrene then reacts by insertion into C™H or C™C
bonds. Alternatively, other reactive intermediates such
as the seven-membered heterocyclic tropolone can form
and in turn react with functional groups in neighboring
proteins. The MALDI-MS analysis of ATP azido deriv-
atives has been described by Chen et al. [11]. These
authors recorded MALDI spectra in the negative mode
and detected mainly [MH 26] and [MH 12]
species. The [M  H  26] is proposed to arise from
elimination of N2 and addition of 2H whereas the [M 
H  12] is likely to result from N2 elimination and
addition of oxygen. The species at [M  H  10],
which is not observed in the analysis of azido-ATP is
proposed to be the result of N2 elimination and addition
of H2O. Based on the study by Chen et al. [11] and our
observations, we propose the following interpretation
of the masses observed for the photodegradation prod-
ucts (Scheme 1). The [M  H  10] species results
from elimination of N2 and addition of H2O, possibly
leading to the formation of a hydroxylamine. The
species at [MH 26] is most likeley the result of N2
elimination and addition of 2 hydrogen atoms which
could lead to the formation of an amine. Loss of the
azido group (N3) should lead to a species at [M  H 
42], whereas we observe a signal at   43. We
interpret this as a non-protonated species, thus [M 
42] corresponds with the positively charged molecule
ion that has lost the N3
 anion.
To investigate the differences in the matrices ability
to protect photolabile peptides from degradation by
Scheme 1. Photodegradation products of the
starting material and possible end products arelaser illumination, we recorded UV spectra of the ma-
trices employed (Figure 3). Of the the three matrices,
sinapinic acid exhibits the highest absorbance near the
wavelength of the laser employed (337 nm). The absor-
bance of both ACHC and DHB is approximately 3-fold
lower in this wavelength region. The matrices em-
ployed for this study are chemically similar com-
pounds, i.e., they are aromatic carboxylic acids. All
three carry hydroxyl functions on the aromatic ring and
two (ACHC and sinapinic acid) are cinnamic acid
derivatives. While it cannot be excluded that differences
in their gas phase chemistry play a role in their reactiv-
ity towards azido modified peptides, we propose that
their light absorbance characteristics are a predominant
factor. Thus, the ability of sinapinic acid to absorb the
excitation laser’s light is likely to lead to a protection of
the analyte from photodegradation.
zoylazido group. The mass differences to the
n.
Figure 3. UV spectra of sinapinic acid (solid line), ACHC (short
dashed line), and DHB (long dashed line). The matrices were
dissolved at a concentration of 45 M in 0.3% trifluoroacetic acid,
30% acetonitrile/water.ben
show
1160 LOW ET AL. J Am Soc Mass Spectrom 2004, 15, 1156–1160Conclusions
The results presented here show that azidobenzoyl
peptides undergo photoactivation during MALDI-MS
analysis to a different extent depending the matrix
employed. Analysis by MALDI-MS resulted in the
formation of mainly two reaction products during laser
irradiation, the [M  H  26] and [M  H  10]
species, when ACHC or DHB are used as a matrix.
When sinapinic acid is employed, the authentic azido
peptide [MH] becomes the predominant signal. The
reaction products are proposed to result from loss of N2
and the addition of 2H or H2O, respectively. These
differences in signal abundance for the degraded spe-
cies are likely a consequence of the UV absorbance
characteristics of the matrix molecule compared to the
analyte. The matrix sinapinic acid appears to protect the
analyte from UV irradiation with the highest efficiency.
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